PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F0Y53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $28,608
Award facts
- Contract value 100% obligated
- $28,607.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,607.64 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent contract, valued at up to $999,999,999.00 and extending through December 31, 2031, serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
This delivery order exemplifies AmerisourceBergen's established role as a critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill federal requirements through open competition, consistently delivering diverse pharmaceutical products ranging from diabetes medications to neurological treatments and pain management pharmaceuticals. The firm fixed-price structure and relatively modest value of this particular task order reflect the flexibility of the overarching IDC vehicle in accommodating both routine supply needs and specialized medical commodity requirements across multiple therapeutic domains for the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2D826F0Y53?
SPE2D826F0Y53 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826F0Y53 worth?
The government has obligated $28,608 on SPE2D826F0Y53.
Is contract SPE2D826F0Y53 an order under another contract?
Yes. SPE2D826F0Y53 is a delivery order under SPE2DX22D0089, an indefinite delivery contract.
Was contract SPE2D826F0Y53 competed?
The extent of competition for SPE2D826F0Y53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award